From the category archives:
Direxion, a pioneer in the 3x leveraged ETF space, announced Thursday the launch of six new funds, bringing the firm’s total product offerings to 34, and represent firsts for both the company and the ETF industry. The leveraged ETFs beginning trading on Thursday include: [click to continue…]
{ 0 comments }
ProShares, a leading provider of inverse and leveraged ETFs, has filed for approval on seven addition ETFs, including four “ultra” international ETFs and three products focusing on a popular regional bank index. The international ETFs complement four existing 200% inverse products, and include: [click to continue…]
{ 0 comments }
Direxion announced the expansion of its fixed income product line on Thursday with the launch of two leveraged ETFs targeting a short-term Treasury index. The Direxion Daily 2-Year Treasury Bull 3x Shares (TWOL) seeks 300% of the daily performance of the NYSE Arca Current 2-Year U.S. Treasury Index, a benchmark that consists of the most [...]
{ 0 comments }
ProShares, the ETF issuer known for its 2x leveraged and inverse ETFs, announced today the launch of eight new 3x and -3x leveraged ETFs covering four major U.S. equity indexes. The benchmarks covered by the new ETFs include the NASDAQ-100, Dow Jones Industrial Average, S&P MidCap 400, and Russell 2000.
{ 0 comments }
ProShares, the issuer responsible for pioneering leveraged and inverse ETFs, has filed prospectuses for 16 new funds. Expansion is nothing new for ProShares–the company has launched a handful of new ETFs over the last year–but the filing was interesting because it detailed plans for 300% leveraged ETFs. ProShares’ current product line, which consists of more [...]
{ Comments on this entry are closed }
ProShares made an addition to its line of leveraged fixed income products on Thursday, launching the Ultra 7-10 Year Treasury (UST) and Ultra 20+ Year Treasury (UBT). UST seeks daily investment results that correspond to 200% of the daily performance of the Barclays Capital 7-10 Year U.S. Treasury Index, while UBT will seek to deliver [...]
{ Comments on this entry are closed }
One of the major stories in the ETF industry over the last year has centered on the appropriate uses and potential abuses of leveraged ETFs. In the wake of the unprecedented equity market volatility during 2008 and the first quarter, some investors expressed dismay over the performance of 2x and 3x leveraged funds over multiple [...]
{ Comments on this entry are closed }
Leveraged ETFs were in the headlines a great deal in 2009, but most of the coverage was less than favorable. Misinformation on these products was widespread throughout the year, leading to confusion on many aspects of these products and some unfair generalizations.
One of the primary points of discussion was the performance of leveraged ETFs when [...]
{ Comments on this entry are closed }
Effective December 1, the Financial Regulatory Authority (FINRA) will implement new margin requirements for leveraged ETFs and uncovered options overlying leveraged ETFs. Under Regulatory Notice 09-53, which was first released in August of this year, margin requirements for leveraged and inverse leveraged funds will increase significantly beginning on Tuesday.
{ Comments on this entry are closed }
Bethesda, Maryland-based ProShares announced on Tuesday that it expects to pay zero 2009 year-end capital gains distributions on all 77 of its leveraged and inverse equity and fixed income exchange-traded funds, putting at ease any investors who had been questioning the tax efficiency of leveraged funds. “While we manage ProShares to minimize capital gain distributions, [...]
{ Comments on this entry are closed }
Over the last year, leveraged ETFs have been the subject of intense scrutiny from a number of parties, including regulatory agencies, state governments, broker-dealers, individual investors, and even class action lawyers. While several aspects of leveraged ETFs have been thoroughly analyzed and debated, perhaps no issue has drawn more attention than the effects of compounding [...]
{ Comments on this entry are closed }
Leveraged ETFs have been bashed quite a bit in the financial press quite in recent months, as investors who haven’t quite been able to grasp the complexities of these products have lashed out at issuers for offering what they view to be defective products. A great deal of the complaints about leveraged ETFs (which, unfortunately, [...]
{ Comments on this entry are closed }
Copyright © 2009–2010 Carolean Capital Partners LLC.
All rights reserved. Financial data provided by
.
